Antimicrobials
Azithromycin

Azithromycin

Medium
See Additional Information
PO: 1.63$ IV: 12.93$

Spectrum of Activity

Dosing

General Information

  • Community acquired pneumonia
  • Pertussis
  • Upper respiratory tract infections
  • Chlamydial infections
  • Mycobacterial infections
  • Mycobacterium avium complex (MAC) prophylaxis in HIV patients

Monitor QTc in patients with increased risk

Prolongation of QTc interval. Association with increased cardiovascular mortality in observational studies.

Prolonged half life may contribute to macrolide resistance.

  • Other drugs that prolong QTc
  • Increases cyclosporine levels
  • May increase digoxin levels
  • Statins increased risk of rhabdomyolysis

Bioavailability: 37% - low

  • The low bioavailability is compensated with very high tissue penetration.
  • Very high tissue penetration and concentration intracellularly means in vivo activity may not be predicted by in vitro testing - e.g. Salmonella species.

Antimicrobial class: Macrolide

Pregnancy category: B

Average serum half life: 68 hours

Urine penetration: Poor

Lung penetration: Therapeutic

CSF penetration: Poor

Biliary penetration: Therapeutic